Özlem Bolat Kaya1, Hasan Kaya2, Aybeniz Civan Kahve2, Aslı Enez Darçin3, Raziye Serçin Yalçin Çavuş4, Nesrin Dilbaz5. 1. Psychiatrist at Private Practice, Ankara, Turkey. 2. Department of Psychiatry, University of Health Sciences Ankara City Hospital, Ankara, Turkey. 3. Department of Psychology, İstanbul Ayvansaray University, İstanbul, Turkey. 4. Psychiatrist at Private Practice, Uşak, Turkey. 5. Department of Psychiatry, Üsküdar University Faculty of Medicine, İstanbul, Turkey.
Abstract
Introduction: The relationship between BDNF gene Val/Met polymorphism and clinical symptoms, attention and executive functions in patients with schizophrenia was investigated in this study. Also, BDNF Val66Met gene polymorphism was compared between patients and healthy controls. Thus, genetic factors that may affect both the etiology and cognitive functions in schizophrenia were evaluated. Methods: BDNF Val66Met gene polymorphism was investigated in 102 patients with schizophrenia and 98 healthy controls. Cognitive functions were evaluated by the Wisconsin Card Sorting Test (WCST) and Stroop Test. Results: There was no difference in terms of the genotypic or allelic distribution of BDNF Val66Met polymorphism between patients and healthy controls. A significantly higher percentage of suicide attempts were found in the patients having Met allele (Val/Met and Met/Met). Met allele was associated with failure in focused attention and response inhibition in patients with schizophrenia. Conclusion: The presence of the Met allele could be associated with the risk of suicide attempts in patients with schizophrenia. Impairment in executive function areas such as focused attention and response inhibition appears to be related to the Met allele. Copyright:
Introduction: The relationship between BDNF gene Val/Met polymorphism and clinical symptoms, attention and executive functions in patients with schizophrenia was investigated in this study. Also, BDNF Val66Met gene polymorphism was compared between patients and healthy controls. Thus, genetic factors that may affect both the etiology and cognitive functions in schizophrenia were evaluated. Methods: BDNF Val66Met gene polymorphism was investigated in 102 patients with schizophrenia and 98 healthy controls. Cognitive functions were evaluated by the Wisconsin Card Sorting Test (WCST) and Stroop Test. Results: There was no difference in terms of the genotypic or allelic distribution of BDNF Val66Met polymorphism between patients and healthy controls. A significantly higher percentage of suicide attempts were found in the patients having Met allele (Val/Met and Met/Met). Met allele was associated with failure in focused attention and response inhibition in patients with schizophrenia. Conclusion: The presence of the Met allele could be associated with the risk of suicide attempts in patients with schizophrenia. Impairment in executive function areas such as focused attention and response inhibition appears to be related to the Met allele. Copyright:
Authors: M Dieci; A Vita; C Silenzi; A Caputo; M Comazzi; L Ferrari; L Ghiringhelli; M Mezzetti; F Tenconi; G Invernizzi Journal: Schizophr Res Date: 1997-05-03 Impact factor: 4.939
Authors: Clement C Zai; Mirko Manchia; Vincenzo De Luca; Arun K Tiwari; Nabilah I Chowdhury; Gwyneth C Zai; Ryan P Tong; Zeynep Yilmaz; Sajid A Shaikh; John Strauss; James L Kennedy Journal: Int J Neuropsychopharmacol Date: 2011-08-30 Impact factor: 5.176
Authors: Nancy C Andreasen; William T Carpenter; John M Kane; Robert A Lasser; Stephen R Marder; Daniel R Weinberger Journal: Am J Psychiatry Date: 2005-03 Impact factor: 18.112
Authors: Janusz K Rybakowski; Alina Borkowska; Piotr M Czerski; Maria Skibińska; Joanna Hauser Journal: Bipolar Disord Date: 2003-12 Impact factor: 6.744
Authors: Janusz K Rybakowski; Alina Borkowska; Maria Skibinska; Aleksandra Szczepankiewicz; Pawel Kapelski; Anna Leszczynska-Rodziewicz; Piotr M Czerski; Joanna Hauser Journal: Psychiatry Clin Neurosci Date: 2006-02 Impact factor: 5.188